Iowa City, IA4 Active Studies

Heart Attack Clinical Trials in Iowa City, IA

Find 4 actively recruiting heart attack clinical trials in Iowa City, IA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,335
Enrolling

Recruiting Heart Attack Studies in Iowa City

RecruitingIowa City, IANCT04262466

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Brenetafusp (IMC-F106C) is an immune-mobilizing monoclonal T cell receptor against cancer (ImmTAC ®) designed for the treatment of cancers positive for the tumor-associated antigen PRAME. This is a fi...

727 participants
Immunocore Ltd
View Study Details
RecruitingIowa City, IANCT04065399

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Phase 1 dose escalation will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of revumenib in participants with acute leukemia. In Phase 2, participants will be enrolled...

413 participants
Syndax Pharmaceuticals
View Study Details
RecruitingIowa City, IANCT06384261

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

The goal of this clinical trial is to learn if participants treated with the experimental drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to v...

120 participants
OncoVerity, Inc.
View Study Details
RecruitingIowa City, IANCT05932680

Limited-duration Teclistamab

This is a single-arm, non-inferiority study in which patients who have achieved a very good partial response (VGPR) or better, according to International Myeloma Working Group (IMWG) response criteria...

75 participants
Abramson Cancer Center at Penn Medicine
View Study Details

About Heart Attack Clinical Trials in Iowa City

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 4 heart attack clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 1,335 participants. Research is being sponsored by Immunocore Ltd, Syndax Pharmaceuticals, OncoVerity, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Iowa City — FAQ

Are there heart attack clinical trials in Iowa City?

Yes, there are 4 heart attack clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Iowa City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.

Are clinical trials in Iowa City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 4 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated March 2, 2026 from ClinicalTrials.gov